{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-26-000115","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2026-07-30T20:05:40+00:00","discovered_at":"2026-07-30T20:06:18.375453+00:00","generated_at":"2026-07-30T20:06:34.322988+00:00","sec_items":["1.01","1.02","2.01","2.03","3.01","3.03","5.01","5.02","5.03","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"AIP completes acquisition of Avanos for $1.272B; stockholders receive $25.00/share cash","bullets":["Deal valued at ~$1.272B; Avanos stockholders get $25.00 per share in cash.","Avanos common stock delisted from NYSE; company becomes private.","New board: David Pacitti CEO, Scott Galovan CFO, John Fischer General Counsel.","Credit agreement: $675M term loan, $100M DDTL, $100M revolver, matures 2033.","Prior directors resigned; Joel Rotroff (AIP) initially appointed then replaced."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-26-000115","json":"https://secwatch.observer/filing/0001606498-26-000115.json","markdown":"https://secwatch.observer/filing/0001606498-26-000115.md","text":"https://secwatch.observer/filing/0001606498-26-000115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/0001606498-26-000115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/avns-20260727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:06:34.322988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}